IP Library Granted Patent US 10,561,774
Granted Patent B2
US 10,561,774 · App. 15/648,735 · Granted Feb 18, 2020

HVAD circadian tracker (PHI+)

Inventors: Neil Voskoboynikov (Pembroke Pines, FL); Pedro E. Grave De Peralta (Hialeah, FL); Veronica Ramos (Miami, FL)
Assignee: HeartWare, Inc.
A61M1/122A61M1/101A61M1/1086A61M2205/3327
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,561,774
App. No.
15/648,735
Granted
Feb 18, 2020
Kind
B2
Abstract

A method of detecting a disruption in a diurnal rhythm of a patient having an implantable blood pump comprising calculating a moving average convergence divergence (MACD) based on power consumed by the implantable blood pump to maintain a constant rotational speed of an impeller of the implantable blood pump and generating an alert when the calculated MACD does not cross a MACD zero line for a predetermined MACD zero line crossing time threshold.

Claims (29)

1. A method of detecting a disruption in a diurnal rhythm of a patient having an implantable blood pump, comprising:

calculating a moving average convergence divergence (MACD) based on power consumed by the implantable blood pump to maintain a constant rotational speed of an impeller of the implantable blood pump; and

generating an alert when the calculated MACD does not cross a MACD zero line for a predetermined MACD zero line crossing time threshold.

2. The method of claim 1 , wherein the MACD zero line crossing time threshold is 24 hours.

3. The method of claim 1 , wherein calculating the MACD includes calculating a slow moving average (SMA), and wherein the SMA is a one second average measurement of the power consumed by the implantable blood pump measured at a predetermined interval for a first predetermined period of time.

4. The method of claim 3 , wherein the predetermined interval is 15 minutes.

5. The method of claim 4 , wherein the first predetermined period of time is 48 hours.

6. The method of claim 3 , wherein calculating the MACD includes calculating a fast moving average (FMA), and wherein the FMA is a one second average measurement of the power consumed by the implantable blood pump measured at the predetermined interval for a second predetermined period of time less the first period of time.

7. The method of claim 6 , wherein the second predetermined period of time is four hours.

8. The method of claim 1 , wherein the patient has a diurnal cycle, and wherein generating the alert is indicative of a loss of the patient's diurnal cycle.

9. The method of claim 8 , wherein the method further includes correlating the loss of the patient's diurnal cycle to at least one from the group consisting of thrombus and tachycardia.

10. The method of claim 1 , wherein generating an alert includes at least one from group consisting of sounding an alarm on a controller of the implantable blood pump and displaying a time and date of the alert in a log file of a controller of the implantable blood pump.

11. A system of detecting a disruption in a diurnal rhythm of a patient having an implantable blood pump, comprising:

a controller having a processor, the controller being in communication with the implantable blood pump and a power source configured to provide power to the implantable blood pump, the controller being configured to:

calculate a moving average convergence divergence (MACD) based on power consumed by the implantable blood pump to maintain a constant rotational speed of an impeller of the implantable blood pump; and

generate an alert when the calculated MACD does not cross a MACD zero line for a predetermined MACD zero line crossing time threshold.

12. The system of claim 11 , wherein the MACD zero line crossing time threshold is 24 hours.

13. The system of claim 11 , wherein calculating the MACD includes calculating a slow moving average (SMA), and wherein the SMA is a one second average measurement of the power consumed by the implantable blood pump measured at a predetermined interval for a first predetermined period of time.

14. The system of claim 13 , wherein the predetermined interval is 15 minutes.

15. The system of claim 14 , wherein the first predetermined period of time is 48 hours.

16. The system of claim 13 , wherein calculating the MACD includes calculating a fast moving average (FMA), and wherein the FMA is a one second average measurement of the power consumed by the implantable blood pump measured at the predetermined interval for a second predetermined period of time less the first period of time.

17. The system of claim 16 , wherein the second predetermined period of time is four hours.

18. The system of claim 11 , generating an alert includes at least one from group consisting of sounding an alarm on a controller of the implantable blood pump and displaying a time and date of the alert on a display of a controller of the implantable blood pump.

19. The system of claim 11 , wherein the controller is further configured to clear the alert when the calculated MACD crosses the MACD zero line for the predetermined MACD zero line crossing time threshold.

20. A method of detecting a disruption in a diurnal rhythm of a patient having an implantable blood pump and a diurnal cycle, comprising:

calculating a moving average convergence divergence (MACD) based on power consumed by the implantable blood pump to maintain a constant rotational speed of an impeller of the implantable blood pump; and

generating an alert when the calculated MACD does not cross a MACD zero line for a predetermined MACD zero line crossing time threshold, the alert being indicative of a loss of the patient's diurnal cycle, the generating an alert includes at least one from group consisting of sounding an alarm on a controller of the implantable blood pump and displaying a time and date of the alert in a log file of a controller of the implantable blood pump;

correlating the loss of the patient's diurnal cycle to at least one from the group consisting of thrombus and tachycardia; and

clearing the alert when the calculated MACD crosses the MACD zero line for the predetermined MACD zero line crossing time threshold.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2024
From: HEARTWARE, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 069432/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2017
From: VOSKOBOYNIKOV, NEIL; GRAVE DEPERALTA, PEDRO E.; RAMOS, VERONICA
To: HEARTWARE, INC.
Reel/Frame 043710/0883 →
Continuity (1)
Related Publication 20190015571A1 · Jan 17, 2019